Transfusion Thresholds in Myocardial Infarcti...

Dr. Centor discusses glucagon-like peptide-1 receptor agonists, weight loss, and body composition with Dr. John Batsis. 

Dr. Centor discusses thiamine deficiency with Dr. Adam Goldman. 

Can the MINT trial change how we treat anemia in acute MI? The largest trial of its kind compared liberal vs. restrictive transfusion strategies in patients with myocardial infarction.Sponsor: Freed is an AI scribe that listens and writes your note in < 30 seconds. Freed learns y ...  Show more

Annnnnnnnd We are back. Sorry, but after Andor has finally finished we have now got time to discuss the old type 1 MI, aka STEMI aka Occlusive Myocardial Infarction. Come listen for all those basics and some nuances around myocardial infarction in critically unwell patients. We t ...  Show more

Dr. Venu Menon, Director of the Cardiovascular Fellowship Program and Section Head, Clinical Cardiology and Chetan Huded MD, Interventional Fellow discuss incidence of stroke up to 30 days after TAVR. Dr. Huded published his findings in JAMA . Drs. Menon and Huded discuss the pat ...  Show more

Obstructive hypertrophic cardiomyopathy therapy and septal reduction therapy via alcohol septal ablation and surgical myectomy is discussed by interventional cardiologist Dr. Amar Krishnaswamy and surgical perspective from cardiothoracic surgeon Dr. Per Wierup. Amit joins Dr. Lau ...  Show more